Page 60 - Read Online
P. 60

± 94.2%). NPV were available in 13 studies reaching values   by the lymphatic system may vary and are dependent on
         between 88% and 100% (mean ± 94.4%).                the size of the particles. Small particles are drained and
                                                             cleared first; large particles are drained and cleared last
         In only 5 works, the survival data were displayed in terms   and may be retained longer at the injection site. There
         of DFS, OS and DSS regard the SLNB results. These 5 works   is worldwide variation in radiopharmaceuticals used for
         showed the data detailing the positivity or negativity of the   lymphoscintigraphy. Tc-99m sulphur colloid is employed in
         nodes biopsied. In only 2 studies the terms of survival were   the USA, with an average size ranging from 305 nm to 340
         also displayed depending of the type of node invasion, isolated   nm and Tc-99m-nanocolloid are used in Europe with size
                                                                                       [30]
         tumoral cells (ITC), micrometastases or macrometastases. [24,26]  All   ranging from 5 nm to 100 nm.  Studies have shown that
         type of node invasion showed significant differences in terms of   the success rate of identification of SNs is not significantly
         DFS, OS and DSS respect to the absence of node invasion. The   affected by the particle size of the radiotracer. [31-34]  Thus, the
         two works were published by Broglie et al. [24,26]  in 2011 and 2013   selection of radiotracer is based more on local availability
         obtaining very similar values for DFS for the pathological results   than on differences in sentinel lymph node (SLN) detection.
         of SNB negative, ITC, micrometastases and macrometastases.
         Those results were: 96% and 98%, 80% and 75%, 69% and 71%,   Recent developments in new tracers are coming, like the use
         62% and 67%, respectively. The values obtained for OS for the   of indocyanine green-Tc99m-nanocolloid, a hybrid tracer that is
         same pathological results were: 88% and 98%, 80% and 89%, 75%   both radioactive and fluorescent. The addition of fluorescence
         and 71%, 62% and 67%, respectively. Finally, the values obtained   imaging was shown to be of particular value when SNs were
         for DSS for those pathological results were: 96% and 95%, 80%   located in close proximity to the primary tumour. [35]
         and 75%, 75% and 66%, 73% and 65%, respectively [Table 2].
                                                                        ©
                                                             Tilmanocept , is another novel receptor-targeted radio-
         DISCUSSION                                          pharmaceutical, Tc99m-labeled non-particulate radiotracer with
                                                             high affinity for the macrophages and dendritic cells, within
         SNB is a well contrasted technique for the regional   the sentinel lymph node. Studies have been promising, with
         evaluation of tumor staging in breast cancer and melanoma   suggestions that tilmanocept may have improved clearance
         included in international guidelines of management of   from the site of the primary tumor and enhanced retention
         these tumors. [10,11]  However, in OSCC it still remains with   within the sentinel node when compared to sulfur colloid. [36]
         an investigational role. This procedure is very complicated
         in head and neck tumors because of the great wealth   Based upon the experience accumulated in SNLB in other
         of lymphatic vessels and a great variability of regional   tumors, consensus on the activity to be administered in a
         lymphatic migration. We selected articles published in the   SNB procedure has not been reached. The investigated and
         last 5 years, as accumulated experience has induced some   suggested activities vary considerably. Activities as low as
                                                                            [37]
                                                                                                        [36]
         evolution in radioisotope procedures, imaging techniques   3.7 MBq (0.1 mCi)  and as high as 370 MBq (10 mCi)  have
         and radio-surgery procedures. We included 2 interesting   been used. In our review, the doses ranged between 10 and
         prospective papers published in 2002 and 2004 because   80 MBq, the adequate dose if the tracer administration is
         they reach every required criteria, with high number of   performed the day before surgery, especially if we are going
         patients and included detailed data of survival respect to   to acquire SPECT-CT images that require greater tracer
         the histological findings of IHC. [27,28]           activity. These doses do not imply a significant radiation dose
                                                             to the workers in the operation room. Note that between
         We selected only prospective studies because they imply an   administration of the radiotracer and surgery usually pass at
         approach and prior review of the different techniques used. In   least 24 h. It means that an administered dose will become
         OSCC, the first studies have only been published since 1999,   to 1/16 of the injected at the operation time, so that no
         7 years after the technique gained acceptance in breast and   specific radioprotection precautions are required.
         melanoma. This, combined with the reduced incidence of oral
         cancers compared to melanoma and breast cancer, necessarily   Radiotracer administration
                                                                                                             [25]
         results in a low number of studies with more than 30 patients,   Respect to the volume of radiotracer injected, Chone et al.
         but it is similar to some meta-analysis reviewed. [29]  employed the largest volume per dose (0.5 mL) in an attempt
                                                             to completely surround the tumor in its deep and lateral
         Radiotracer                                         aspects at a sub-mucous level of normal mucous membrane
         Seven studies employed Tc99m-nanocolloid as radiotracer   that surrounds the tumor in a volume of approximately
         and 6 used Tc99m-sulphur colloid [Table 1]. Values of SS   1-2 mL. However, we did not find any significant difference
         and NPV ranged between 88-100% and 86-100% with Tc99m-  in terms of SS or NPV. In breast cancer with peritumoral
         nanocolloid, and between 80-95% and 93-98% with sulphur   injections, larger volumes per dose (i.e. 0.5-1.0 mL) are
                                                                                       [33]
         colloid. The number of studies is very low but there were   preferred for the same reason.  Perhaps the best option
         no significant differences.                         would be to try the peritumoral region completely
                                                             surrounded by the radiotracer to avoid false negative results.
         Several 99mTc-based agents have been used for radioguided
         SNB. The ideal radiotracer should show rapid transit to   SN preoperative localization
         SNs with prolonged retention in the nodes. In general, the   The most common method to preoperatively localize
         drainage, distribution, and clearance of radioactive colloids   SN included injecting a radioactive sentinel node tracer
         146                                                                     Plast Aesthet Res || Volume 3 || May 25, 2016
   55   56   57   58   59   60   61   62   63   64   65